Microcontroller units (MCUs) are single-chip computers optimized for performing embedded computing tasks like controlling a ...

The plausible mechanism pathway "could accelerate gene therapy/editing development," analysts at William Blair said Thursday, ...

Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing ...

Despite the rapid invention and widespread use of artificial intelligence (AI), the federal government is just beginning to shape the ...

Good morning, and welcome to the PAVmed's Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I would now like to ...

Boston Scientific’s FARAPULSE Pulsed Field Ablation (PFA) system is making waves in how doctors treat irregular heart ...

Drugs approved by the FDA’s expanding program to expedite reviews for products in line with the Trump administration’s agenda ...

Celcuity (CELC) announced the completion of the submission of its new drug application to the FDA for gedatolisib in hormone receptor positive, ...

Private certification, insurer evaluation and peer-reviewed research step up.

FDA grants Fast Track designation to DPTX3186, Dewpoint’s first in class condensate modulator for gastric cancerDesignation provides increased ...

In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce ...

The “plausible mechanism” pathway, outlined by Martin Makary and Vinay Prasad, is designed to help accelerate treatments ...